BlackRock Institutional Trust’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$10.3M Buy
319,470
+79,980
+33% +$2.05M ﹤0.01% 2391
2016
Q3
$6.27M Buy
239,490
+24,121
+11% +$631K ﹤0.01% 2602
2016
Q2
$4.99M Buy
215,369
+66,879
+45% +$1.67M ﹤0.01% 2686
2016
Q1
$4.06M Buy
148,490
+21,737
+17% +$455K ﹤0.01% 2762
2015
Q4
$3.61M Buy
126,753
+7,849
+7% +$211K ﹤0.01% 2871
2015
Q3
$2.08M Buy
118,904
+39,552
+50% +$774K ﹤0.01% 3110
2015
Q2
$1.43M Buy
79,352
+30,149
+61% +$412K ﹤0.01% 3246
2015
Q1
$613K Buy
49,203
+453
+0.9% +$5.64K ﹤0.01% 3468
2014
Q4
$573K Buy
48,750
+20,985
+76% +$244K ﹤0.01% 3473
2014
Q3
$365K Buy
+27,765
New +$360K ﹤0.01% 3538

Other funds holding LOXO

BlackRock Institutional Trust's LOXO Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Loxo Oncology, Inc (LOXO) stake by 33% in Q4 2016, buying an estimated $2.05M and bringing the position to 319,470 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2391.

BlackRock Institutional Trust first reported a position in LOXO in Q3 2014 and has held it in 10 quarters since. 86 funds tracked by Wall St. Rank hold LOXO as of Q4 2016.

  • BlackRock Institutional Trust held 319,470 shares of Loxo Oncology, Inc worth $10.3M as of Q4 2016.
  • BlackRock Institutional Trust bought 79,980 Loxo Oncology, Inc shares in Q4 2016, an estimated $2.05M.
  • Loxo Oncology, Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2391 holding.
  • BlackRock Institutional Trust first reported a position in Loxo Oncology, Inc in Q3 2014 and has held it in 10 quarters since.
  • 86 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.